Titre : Benzoate de sodium

Benzoate de sodium : Questions médicales fréquentes

Termes MeSH sélectionnés :

Double-Blind Method
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Benzoate de sodium : Questions médicales les plus fréquentes", "headline": "Benzoate de sodium : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Benzoate de sodium : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-08", "dateModified": "2025-03-05", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Benzoate de sodium" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Acide benzoïque", "url": "https://questionsmedicales.fr/mesh/D019817", "about": { "@type": "MedicalCondition", "name": "Acide benzoïque", "code": { "@type": "MedicalCode", "code": "D019817", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.127.117" } } }, "about": { "@type": "MedicalCondition", "name": "Benzoate de sodium", "alternateName": "Sodium Benzoate", "code": { "@type": "MedicalCode", "code": "D020160", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Chieh-Hsin Lin", "url": "https://questionsmedicales.fr/author/Chieh-Hsin%20Lin", "affiliation": { "@type": "Organization", "name": "Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan." } }, { "@type": "Person", "name": "Hsien-Yuan Lane", "url": "https://questionsmedicales.fr/author/Hsien-Yuan%20Lane", "affiliation": { "@type": "Organization", "name": "Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan." } }, { "@type": "Person", "name": "Andrea Baker", "url": "https://questionsmedicales.fr/author/Andrea%20Baker", "affiliation": { "@type": "Organization", "name": "Queensland Centre for Mental Health Research, The Park Centre for Mental Health, Wacol, Australia." } }, { "@type": "Person", "name": "Anne Gordon", "url": "https://questionsmedicales.fr/author/Anne%20Gordon", "affiliation": { "@type": "Organization", "name": "Metro North Mental Health, Royal Brisbane and Women's Hospital, Herston, Australia." } }, { "@type": "Person", "name": "George Bruxner", "url": "https://questionsmedicales.fr/author/George%20Bruxner", "affiliation": { "@type": "Organization", "name": "Metro North Mental Health, Caboolture and Redcliffe Hospitals, Caboolture, Australia." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "A Randomized Double-Blind, Placebo-Controlled Study on Anti-Stress Effects of Nelumbinis Semen.", "datePublished": "2022-06-29", "url": "https://questionsmedicales.fr/article/35805620", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph19137963" } }, { "@type": "ScholarlyArticle", "name": "Naltrexone/bupropion for binge-eating disorder: A randomized, double-blind, placebo-controlled trial.", "datePublished": "2023-09-26", "url": "https://questionsmedicales.fr/article/37751990", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/oby.23898" } }, { "@type": "ScholarlyArticle", "name": "RDN for the treatment of influenza in children: a randomized, double-blinded, parallel-controlled clinical trial.", "datePublished": "2023-07-20", "url": "https://questionsmedicales.fr/article/37474974", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12906-023-04037-1" } }, { "@type": "ScholarlyArticle", "name": "Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial.", "datePublished": "2022-11-25", "url": "https://questionsmedicales.fr/article/36442484", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/S0140-6736(22)02324-8" } }, { "@type": "ScholarlyArticle", "name": "RESCUE BT 2, a multicenter, randomized, double-blind, double-dummy trial of intravenous tirofiban in acute ischemic stroke: Study rationale and design.", "datePublished": "2022-09-07", "url": "https://questionsmedicales.fr/article/35993176", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/17474930221122681" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés chimiques organiques", "item": "https://questionsmedicales.fr/mesh/D009930" }, { "@type": "ListItem", "position": 3, "name": "Hydrocarbures", "item": "https://questionsmedicales.fr/mesh/D006838" }, { "@type": "ListItem", "position": 4, "name": "Hydrocarbures cycliques", "item": "https://questionsmedicales.fr/mesh/D006844" }, { "@type": "ListItem", "position": 5, "name": "Hydrocarbures aromatiques", "item": "https://questionsmedicales.fr/mesh/D006841" }, { "@type": "ListItem", "position": 6, "name": "Dérivés du benzène", "item": "https://questionsmedicales.fr/mesh/D001555" }, { "@type": "ListItem", "position": 7, "name": "Benzoates", "item": "https://questionsmedicales.fr/mesh/D001565" }, { "@type": "ListItem", "position": 8, "name": "Acide benzoïque", "item": "https://questionsmedicales.fr/mesh/D019817" }, { "@type": "ListItem", "position": 9, "name": "Benzoate de sodium", "item": "https://questionsmedicales.fr/mesh/D020160" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Benzoate de sodium - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Benzoate de sodium", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-14", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Benzoate de sodium", "description": "Comment diagnostiquer une allergie au benzoate de sodium ?\nQuels tests sont utilisés pour évaluer l'exposition au benzoate ?\nQuels symptômes indiquent une intoxication au benzoate ?\nComment évaluer une réaction cutanée au benzoate ?\nLe benzoate de sodium peut-il être détecté dans les tests de toxicologie ?", "url": "https://questionsmedicales.fr/mesh/D020160?mesh_terms=Double-Blind+Method&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Benzoate de sodium", "description": "Quels sont les symptômes d'une hypersensibilité au benzoate ?\nLe benzoate de sodium cause-t-il des effets secondaires ?\nComment se manifeste une réaction allergique au benzoate ?\nLe benzoate de sodium peut-il provoquer des troubles digestifs ?\nQuels symptômes neurologiques peuvent être liés au benzoate ?", "url": "https://questionsmedicales.fr/mesh/D020160?mesh_terms=Double-Blind+Method&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Benzoate de sodium", "description": "Comment éviter les allergies au benzoate de sodium ?\nQuelles alternatives au benzoate de sodium existent ?\nLes enfants doivent-ils éviter le benzoate ?\nComment sensibiliser sur les dangers du benzoate ?\nLe benzoate de sodium est-il sûr dans les aliments ?", "url": "https://questionsmedicales.fr/mesh/D020160?mesh_terms=Double-Blind+Method&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Benzoate de sodium", "description": "Quel traitement pour une réaction allergique au benzoate ?\nComment traiter une intoxication au benzoate de sodium ?\nY a-t-il des antidotes pour le benzoate de sodium ?\nComment gérer les effets secondaires du benzoate ?\nLe benzoate de sodium nécessite-t-il un suivi médical ?", "url": "https://questionsmedicales.fr/mesh/D020160?mesh_terms=Double-Blind+Method&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Benzoate de sodium", "description": "Quelles complications peuvent survenir avec une allergie au benzoate ?\nLe benzoate de sodium peut-il affecter le foie ?\nY a-t-il des risques de cancer liés au benzoate ?\nLe benzoate de sodium peut-il affecter le système nerveux ?\nQuelles sont les conséquences d'une surconsommation ?", "url": "https://questionsmedicales.fr/mesh/D020160?mesh_terms=Double-Blind+Method&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Benzoate de sodium", "description": "Qui est le plus à risque d'allergie au benzoate ?\nLes personnes asthmatiques sont-elles à risque ?\nLe risque d'allergie augmente-t-il avec l'âge ?\nLes personnes ayant des maladies chroniques sont-elles à risque ?\nLe mode de vie influence-t-il le risque d'allergie ?", "url": "https://questionsmedicales.fr/mesh/D020160?mesh_terms=Double-Blind+Method&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une allergie au benzoate de sodium ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic se fait par des tests cutanés ou des tests sanguins pour détecter des anticorps." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'exposition au benzoate ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de laboratoire peuvent mesurer les niveaux de benzoate dans le sang ou l'urine." } }, { "@type": "Question", "name": "Quels symptômes indiquent une intoxication au benzoate ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des nausées, des vomissements et des douleurs abdominales." } }, { "@type": "Question", "name": "Comment évaluer une réaction cutanée au benzoate ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Une évaluation clinique et un historique médical détaillé sont nécessaires." } }, { "@type": "Question", "name": "Le benzoate de sodium peut-il être détecté dans les tests de toxicologie ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut être détecté dans des tests spécifiques de toxicologie alimentaire." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une hypersensibilité au benzoate ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des démangeaisons, des éruptions cutanées et des maux de tête." } }, { "@type": "Question", "name": "Le benzoate de sodium cause-t-il des effets secondaires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets secondaires comme des nausées et des vertiges peuvent survenir." } }, { "@type": "Question", "name": "Comment se manifeste une réaction allergique au benzoate ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut se manifester par des urticaires, des gonflements et des difficultés respiratoires." } }, { "@type": "Question", "name": "Le benzoate de sodium peut-il provoquer des troubles digestifs ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut entraîner des troubles digestifs comme des douleurs abdominales et des diarrhées." } }, { "@type": "Question", "name": "Quels symptômes neurologiques peuvent être liés au benzoate ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des maux de tête et des vertiges peuvent être observés." } }, { "@type": "Question", "name": "Comment éviter les allergies au benzoate de sodium ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les aliments contenant du benzoate et lisez attentivement les étiquettes." } }, { "@type": "Question", "name": "Quelles alternatives au benzoate de sodium existent ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des conservateurs naturels comme l'acide citrique ou le vinaigre peuvent être utilisés." } }, { "@type": "Question", "name": "Les enfants doivent-ils éviter le benzoate ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants sensibles devraient éviter le benzoate en raison de risques d'hyperactivité." } }, { "@type": "Question", "name": "Comment sensibiliser sur les dangers du benzoate ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des campagnes d'information et des étiquettes claires peuvent aider à sensibiliser." } }, { "@type": "Question", "name": "Le benzoate de sodium est-il sûr dans les aliments ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Il est généralement considéré comme sûr en quantités réglementées, mais des précautions s'imposent." } }, { "@type": "Question", "name": "Quel traitement pour une réaction allergique au benzoate ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les antihistaminiques et les corticostéroïdes peuvent être prescrits pour soulager les symptômes." } }, { "@type": "Question", "name": "Comment traiter une intoxication au benzoate de sodium ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut l'élimination de l'exposition et des soins symptomatiques." } }, { "@type": "Question", "name": "Y a-t-il des antidotes pour le benzoate de sodium ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas d'antidote spécifique, le traitement est symptomatique." } }, { "@type": "Question", "name": "Comment gérer les effets secondaires du benzoate ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Il est conseillé de réduire l'exposition et de consulter un médecin pour des conseils." } }, { "@type": "Question", "name": "Le benzoate de sodium nécessite-t-il un suivi médical ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical est recommandé en cas de réactions sévères ou d'allergies confirmées." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une allergie au benzoate ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications graves comme un choc anaphylactique peuvent survenir dans des cas extrêmes." } }, { "@type": "Question", "name": "Le benzoate de sodium peut-il affecter le foie ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Une exposition excessive peut entraîner des troubles hépatiques, bien que rare." } }, { "@type": "Question", "name": "Y a-t-il des risques de cancer liés au benzoate ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des études suggèrent un lien potentiel avec certains cancers, mais les preuves sont limitées." } }, { "@type": "Question", "name": "Le benzoate de sodium peut-il affecter le système nerveux ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Une exposition excessive peut entraîner des effets neurologiques, comme des maux de tête." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'une surconsommation ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une surconsommation peut entraîner des troubles digestifs et des réactions allergiques." } }, { "@type": "Question", "name": "Qui est le plus à risque d'allergie au benzoate ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes ayant des antécédents d'allergies alimentaires sont plus à risque." } }, { "@type": "Question", "name": "Les personnes asthmatiques sont-elles à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes asthmatiques peuvent être plus sensibles aux effets du benzoate." } }, { "@type": "Question", "name": "Le risque d'allergie augmente-t-il avec l'âge ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Le risque d'allergie peut augmenter chez les enfants, mais il varie selon les individus." } }, { "@type": "Question", "name": "Les personnes ayant des maladies chroniques sont-elles à risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes atteintes de maladies chroniques peuvent avoir une sensibilité accrue." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque d'allergie ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sain peut réduire le risque d'allergies alimentaires, y compris au benzoate." } } ] } ] }

Sources (10000 au total)

Naltrexone/bupropion for binge-eating disorder: A randomized, double-blind, placebo-controlled trial.

Binge-eating disorder (BED) is a prevalent psychiatric disorder associated with obesity. Few evidence-based treatments exist for BED, particularly pharmacological options. This study tested the effica... A randomized, double-blind, placebo-controlled, 12-week trial tested naltrexone/bupropion for BED with and without obesity. Eighty-nine patients (70.8% women, 69.7% White, mean age 45.7 y, mean BMI 35... Mixed models of binge-eating frequency revealed significant reductions that did not differ significantly between naltrexone/bupropion and placebo. Logistic regression of binge-eating remission rates r... Naltrexone/bupropion did not demonstrate effectiveness for reducing binge eating relative to placebo but showed effectiveness for weight reduction in patients with BED. Obesity status did not predict ...

RDN for the treatment of influenza in children: a randomized, double-blinded, parallel-controlled clinical trial.

The morbidity of influenza in children increased rapidly in decade. Reduning injection (RDN), a small but fine Chinese herbal formula, has antipyretic, antiviral, anti-inflammatory effects. We intend ... We design a randomized, double-blind, double-dummy, parallel control of positive drug, multi-centre clinical study. According to the formula of mean superiority test, a total of 240 patients with infl... The study is launched to evaluate the efficacy and safety of RDN for the treatment of influenza in children and to provide an alternative option for influenza in children.... This study is registered in ClinicalTrials.gov as NCT04183725, registered on 3 December, 2019....

Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial.

Rezafungin is a next-generation, once-a-week echinocandin in development for the treatment of candidaemia and invasive candidiasis and for the prevention of invasive fungal disease caused by Candida, ... ReSTORE was a multicentre, double-blind, double-dummy, randomised phase 3 trial done at 66 tertiary care centres in 15 countries. Adults (≥18 years) with systemic signs and mycological confirmation of... Between Oct 12, 2018, and Aug 29, 2021, 222 patients were screened for inclusion, and 199 patients (118 [59%] men; 81 [41%] women; mean age 61 years [SD 15·2]) were randomly assigned (100 [50%] patien... Our data show that rezafungin was non-inferior to caspofungin for the primary endpoints of day-14 global cure (EMA) and 30-day all-cause mortality (FDA). Efficacy in the initial days of treatment warr... Cidara Therapeutics and Mundipharma....

RESCUE BT 2, a multicenter, randomized, double-blind, double-dummy trial of intravenous tirofiban in acute ischemic stroke: Study rationale and design.

Tirofiban is a glycoprotein IIb/IIIa receptor inhibitor that has been shown to be effective in the treatment of acute coronary syndromes. However, it remains unknown whether it improves outcomes in pa... This trial investigates the efficacy and safety of tirofiban compared with aspirin for acute ischemic stroke within 24 h after symptom onset.... The Efficacy and Safety of Tirofiban Compared with Aspirin in the Treatment of Acute Ischemic Stroke (RESCUE BT 2) Trial is an investigator-initiated, prospective, randomized, double-blind, double-dum... The primary endpoint is the proportion of patients with excellent functional outcomes defined as a modified Rankin scale score of 0 to 1 at 90 days after randomization. Lead safety endpoints include m... ChiCTR2000029502 (www.chictr.org.cn)....

Oral dydrogesterone for prevention of miscarriage in threatened miscarriage: a randomized, double-blind, placebo-controlled trial.

To determine the effectiveness of oral dydrogesterone in preventing miscarriage in threatened miscarriage.... A randomized, controlled trial study was conducted among pregnant Thai women at the gestational age of six to less than 20 weeks who visited King Chulalongkorn Memorial Hospital, Department of Obstetr... A total of 100 pregnancies were recruited. Fifty of them were assigned to receive oral dydrogesterone and 50 were assigned to receive placebo. The rate of continuing pregnancy beyond 20 weeks of gesta... Oral dydrogesterone 20 mg/day could not prevent miscarriages in women with threatened miscarriage....

Kalium phosphoricum comp. in patients with neurasthenia: a randomized, double-blind, placebo-controlled clinical trial.

This Phase IV placebo-controlled clinical trial was designed to demonstrate the efficacy and safety of the product Neurodoron (Kalium phosporicum comp., KPC) in patients with neurasthenia.... This monocenter, randomized, double-blind, placebo-controlled, parallel-group clinical trial (registration number: DRKS00003261) was conducted in an outpatient German trial site. Women and men aged 18... In total, 204 patients underwent screening, 78 were randomized in each treatment group, and 77 patients each received treatment (intention-to-treat (ITT) population = 154 patients). For none of the pr... Trial treatment was well tolerated with only a few and minor AEs reported, confirming the markedly good safety of KPC. A significant improvement of neurasthenia was seen for the total study population...

Individualized Homeopathic Medicines in the Treatment of Psoriasis Vulgaris: Double-Blind, Randomized, Placebo-Controlled Trial.

Psoriasis is a chronic inflammatory skin disorder, affecting the trunk and extensor surfaces of the limbs and scalp predominantly. Worldwide prevalence ranges between 0.1 and 11.4%, and in India betwe... This 6-month, double-blind, randomized trial was conducted on 51 patients suffering from psoriasis at the National Institute of Homoeopathy, India. Patients were randomized to receive either individua... Although intragroup changes were significant in both groups in the outcome measures, improvements were significantly higher in the IHMs group than in placebos in PASI scores after 6 months of interven... IHMs exhibited better results than placebos in the treatment of psoriasis. Further research is warranted.... <title>Einleitung</title>Psoriasis ist eine chronisch entzündliche Hauterkrankung, die vor allem den Körperstamm und die Streckseiten der Extremitäten sowie die Kopfhaut betrifft. Die weltweite Präval...